Watch the interview with PolarCool’s CEO Erik Andersson below:
PolarCool boosted by 5-year clinical study results
Medtech company PolarCool has developed PolarCap, a medical device that actively cools down the brain in the acute phase of an injury to decrease concussion symptoms. Results from a 5-year clinical study with the device have just been published in the Journal of Neurotrauma, and PolarCool’s CEO Erik Andersson stopped by the BioStock Studio to discuss the results.
Notiser
BrainCool pausar stroke-studie
PHI får ny vd
AcouSort utökar europeiskt samarbete
Integrum stärker distribution i Ukraina
Active Biotech säkrar patent för tasquinimod
NYHETSBREV
NYHETER
Cereno Scientific går framåt på bred front under Q1
Cinclus Pharma skriver miljardavtal med Zentiva
Iconovo fokuserar på kommersialisering
Kommande event!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region’s leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
Du är värd det bästa!
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
Krönikor
Första draget gjort – nu väntar vi på svar
Osäkerheten gör det svårare att deala
